How much is the genetic testing market worth?

The market size of genetic testing in 2027 is calculated to be USD 27.85 Billion.

How is the genetic testing industry projected to perform over the next decade?

Genetic Testing Market size was over USD 25.07 Billion in 2026 and is likely to grow at 12.79% CAGR between 2027 and 2036, attaining USD 83.53 Billion by 2036.

How is personalized medicine influencing growth in the genetic testing market?

Wider adoption of personalized healthcare is increasing demand for genetic testing to support disease risk assessment, therapy selection, diagnosis, and long-term treatment planning based on individual genetic profiles.

Why are direct-to-consumer services expanding the genetic testing market?

Growing consumer interest in personal health insights and digital health platforms is encouraging broader adoption of direct-to-consumer genetic testing, extending genomics participation beyond traditional clinical settings.

Which products and services segment held the largest share in the genetic testing market?

Kits & reagents accounted for 62.5% of the market in 2026, driven by their routine use across laboratories and clinical testing facilities for disease detection, inherited disorder screening, and precision medicine workflows.

Why is carrier testing expected to be the fastest-growing test type in the genetic testing market?

Carrier testing is expected to grow the fastest as awareness of inherited disease risks increases, encouraging greater use of genetic counseling, reproductive planning, and more accessible genetic testing services.

What makes North America the leading region for genetic testing?

North America held a 49.08% share in 2026, supported by advanced healthcare infrastructure, molecular diagnostics, precision medicine investment, and established research capabilities.

What is driving genetic testing adoption in Asia Pacific?

Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure, improving diagnostic infrastructure, research activity, and growing demand for precise disease detection.

What are the key competitors in the genetic testing landscape?

Major players in the genetic testing market include Illumina, Inc. (United States), Thermo Fisher Scientific Inc. (United States), QIAGEN N.V. (Netherlands), Quest Diagnostics Incorporated (United States), Natera, Inc. (United States), Myriad Genetics, Inc. (United States), BGI Genomics Co., Ltd. (China), 23andMe Holding Co. (United States), Siemens Healthineers AG (Germany), Abbott Laboratories (United States)